Log in to save to my catalogue

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-...

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2646835244

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis

About this item

Full title

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2022-04, Vol.36 (4), p.1025-1034

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Patients with hematological malignancy and COVID-19 display a high mortality rate. In such patients, immunosuppression due to underlying disease and previous specific treatments impair humoral response, limiting viral clearance. Thus, COVID-19 convalescent plasma (CCP) therapy appears as a promising approach through the transfer of neutralizing ant...

Alternative Titles

Full title

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2646835244

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2646835244

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-022-01511-6

How to access this item